Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction |
Kim, Min-Chul
(The Heart Center of Chonnam National University Hospital)
Ahn, Young-Keun (The Heart Center of Chonnam National University Hospital) Jang, Su-Young (The Heart Center of Chonnam National University Hospital) Cho, Kyung-Hoon (The Heart Center of Chonnam National University Hospital) Hwang, Seung-Hwan (The Heart Center of Chonnam National University Hospital) Lee, Min-Goo (The Heart Center of Chonnam National University Hospital) Ko, Jum-Suk (The Heart Center of Chonnam National University Hospital) Park, Keun-Ho (The Heart Center of Chonnam National University Hospital) Sim, Doo-Sun (The Heart Center of Chonnam National University Hospital) Yoon, Nam-Sik (The Heart Center of Chonnam National University Hospital) Yoon, Hyun-Ju (The Heart Center of Chonnam National University Hospital) Kim, Kye-Hun (The Heart Center of Chonnam National University Hospital) Hong, Young-Joon (The Heart Center of Chonnam National University Hospital) Park, Hyung-Wook (The Heart Center of Chonnam National University Hospital) Kim, Ju-Han (The Heart Center of Chonnam National University Hospital) Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital) Cho, Jeong-Gwan (The Heart Center of Chonnam National University Hospital) Park, Jong-Chun (The Heart Center of Chonnam National University Hospital) Kang, Jung-Chaee (The Heart Center of Chonnam National University Hospital) |
1 | Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Pat ients With Unstable Angina/Non-ST-Elevat ion Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-e157. DOI |
2 | Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-1513. DOI ScienceOn |
3 | Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538. DOI ScienceOn |
4 | Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351. DOI ScienceOn |
5 | Glasser SP, Wadley V, Judd S, et al. The association of statin use and statin type and cognitive performance: analysis of the reasons for geographic and racial differences in stroke (REGARDS) study. Clin Cardiol 2010;33:280-288. DOI ScienceOn |
6 | Kato S, Smalley S, Sadarangani A, et al. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase. J Cell Mol Med 2010;14:1180-1193. |
7 | Salman H, Bergman M, Djaldetti M, Bessler H. Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro. Biomed Pharmacother 2008;62:41-45. DOI ScienceOn |
8 | de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004;292:1307-1316. DOI ScienceOn |
9 | Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504. DOI ScienceOn |
10 | Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005;294:2437-2445. DOI ScienceOn |
11 | Lenderink T, Boersma E, Gitt AK, et al. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes. Eur Heart J 2006;27:1799-1804. DOI ScienceOn |
12 | Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278. DOI ScienceOn |
13 | Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129-1135. DOI ScienceOn |
14 | Aikawa M, Rabkin E, Sugiyama S, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001;103:276-283. DOI ScienceOn |
15 | Dangas G, Badimon JJ, Smith DA, et al. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol 1999;33:1294-1304. DOI ScienceOn |
16 | Zile MR. Treating diastolic heart failure with statins: "phat" chance for pleiotropic benefits. Circulation 2005;112:300-303. DOI ScienceOn |
17 | Yoon HE, Song JC, Hyoung BJ, et al. The efficacy and safety of ezetimibe and low-dose simvastatin as a primary treatment for dyslipidemia in renal transplant recipients. Korean J Intern Med 2009;24:233-237. DOI ScienceOn |
18 | Li YH, Wu HL, Yang YH, Tsai HS, Chao TH. Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndrome. Int Heart J 2007;48:677-688. DOI ScienceOn |
19 | Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-28. DOI ScienceOn |
20 | Pasceri V, Patti G, Nusca A, et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004;110:674-678. DOI ScienceOn |
21 | Park JS, Kim YJ, Choi JY, et al. Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia. Korean J Intern Med 2010;25:27-35. DOI ScienceOn |
22 | McKenney JM. Pharmacologic characteristics of statins. Clin Cardiol 2003;26(4 Suppl 3):III32-III38. DOI |
23 | Sakamoto T, Kojima S, Ogawa H, et al. Usef ulness of hydrophilic vs lipophilic statins after acute myocardial infarction: subanalysis of MUSASHI-AMI. Circ J 2007;71:1348-1353. DOI ScienceOn |
24 | Kai T, Arima S, Taniyama Y, Nakabou M, Kanamasa K. Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia: Kinki Adiponectin Interventional (KAI) Study. Clin Exp Hypertens 2008;30:530-540. DOI ScienceOn |
25 | Fujita M, Yamazaki T, Hayashi D, et al. Pleiotropic effects of statins on cardiovascular events in the Japanese Coronary Artery Disease study. Int J Cardiol 2008;129:294-296. DOI ScienceOn |
26 | Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-2241. DOI ScienceOn |